Search Results - "Preston, F.E."

Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT) by VOSSEN, C. Y., CONARD, J., FONTCUBERTA, J., MAKRIS, M., VAN DER MEER, F. J. M., PABINGER, I., PALARETI, G., PRESTON, F. E., SCHARRER, I., SOUTO, J. C., SVENSSON, P., WALKER, I. D., ROSENDAAL, F. R.

“…Background: Reliable risk estimates for venous thrombosis in families with inherited thrombophilia are scarce but necessary for determining optimal screening…”
Get full text

Hereditary thrombophilia and fetal loss: a prospective follow‐up study by Vossen, C. Y., Preston, F. E., Conard, J., Fontcuberta, J., Makris, M., Van Der Meer, F. J. M., Pabinger, I., Palareti, G., Scharrer, I., Souto, J. C., Svensson, P., Walker, I. D., Rosendaal, F. R.

“…Background: As the placental vessels are dependent on the normal balance of procoagulant and anticoagulant mechanisms, inherited thrombophilia may be…”
Get full text

The effects of dietary omega-3 polyunsaturated fatty acids on erythrocyte membrane phospholipids, erythrocyte deformability and blood viscosity in healthy volunteers by Cartwright, I J, Pockley, A G, Galloway, J H, Greaves, M, Preston, F E

“…We have examined, in normal subjects, the effects of a daily dietary supplement of fish oil concentrate ('maxEPA'), providing 3 g of omega-3 fatty acids, on…”
Get more information

Familial thrombophilia and lifetime risk of venous thrombosis by Vossen, C. Y., Conard, J., Fontcuberta, J., Makris, M., Van Der Meer, F. J. M., Pabinger, I., Palareti, G., Preston, F. E., Scharrer, I., Souto, J. C., Svensson, P., Walker, I. D., Rosendaal, F. R.

“…Summary  Background : We started a large multicenter prospective follow‐up study to provide reliable risk estimates of venous thrombosis in families with…”
Get full text

Problems relating to the laboratory diagnosis of factor XIII deficiency: a UK NEQAS study by Jennings, I., Kitchen, S., Woods, T. A. L., Preston, F. E.

“…Familial (F)XIII deficiency is an extremely rare bleeding disorder. In most laboratories the diagnosis is initially established through a clot‐solubility…”
Get full text

Lupus anticoagulant testing using plasma spiked with monoclonal antibodies: performance in the UK NEQAS proficiency testing programme by JENNINGS, I., MACKIE, I., ARNOUT, J., PRESTON, F. E.

“…We report here results from a United Kingdom National Quality Assessment Scheme (UK NEQAS) exercise in which both plasma spiked with monoclonal antibodies and…”
Get full text

Interlaboratory agreement in the monitoring of unfractionated heparin using the anti‐factor Xa‐correlated activated partial thromboplastin time: a rebuttal by KITCHEN, S., PRESTON, F. E., JENNINGS, I., KITCHEN, D.P., WOODS, T.A.L., WALKER, I.

Get full text

SSC/ISTH classification of hemophilia A: can hemophilia center laboratories achieve the new criteria? by Preston, F. E., Kitchen, S., Jennings, I., Woods, T. A. L., Makris, M.

“…To assess the practicality of the recent Scientific and Standardization committee (SSC) of the International Society on Thrombosis and Haemostasis (ISTH)…”
Get full text

Antithrombins Wibble and Wobble (T85M/K): Archetypal Conformational Diseases With In Vivo Latent-Transition, Thrombosis, and Heparin Activation by Beauchamp, N.J., Pike, R.N., Daly, M., Butler, L., Makris, M., Dafforn, T.R., Zhou, A., Fitton, H.L., Preston, F.E., Peake, I.R., Carrell, R.W.

“…The inherent variability of conformational diseases is demonstrated by two families with different mutations of the same conserved aminoacid in antithrombin…”
Get full text

Low-dose aspirin inhibits platelet and venous cyclo-oxygenase in man by Preston, F E, Greaves, M, Jackson, C A, Stoddard, C J

“…In a group of normal subjects we have compared rates of recovery of venous prostacyclin (PGI2) and platelet thromboxane B2 (TXB2) production after a single 300…”
Get more information

Antithrombins Wibble and Wobble (T85M/K) : Archetypal conformational diseases with in vivo latent-transition, thrombosis, and heparin activation by BEAUCHAMP, N. J, PIKE, R. N, CARRELL, R. W, DALY, M, BUTLER, L, MAKRIS, M, DAFFORN, T. R, ZHOU, A, FITTON, H. L, PRESTON, F. E, PEAKE, I. R

“…The inherent variability of conformational diseases is demonstrated by two families with different mutations of the same conserved aminoacid in antithrombin…”
Get full text

Mode of action of dipyridamole on human platelets by Best, L C, McGuire, M B, Jones, P B, Holland, T K, Martin, T J, Preston, F E, Segal, D S, Russell, R G

Get more information

Sensitivity of functional protein S assays to protein S deficiency: a comparative study of three commercial kits by Jennings, I., Kitchen, S., Cooper, P., Makris, M., Preston, F. E.

Get full text

Demonstration of viraemia patterns in haemophiliacs treated with hepatitis-C-virus-contaminated factor VIII concentrates by Garson, J A, Tuke, P W, Makris, M, Briggs, M, Machin, S J, Preston, F E, Tedder, R S

“…Sequential serum samples from previously untreated haemophiliacs in whom non-A, non-B hepatitis (NANBH) developed after they received factor VIII concentrate…”
Get more information

Hepatitis C antibody and chronic liver disease in haemophilia by Makris, M, Preston, F E, Triger, D R, Underwood, J C, Choo, Q L, Kuo, G, Houghton, M

“…A radioimmunoassay was used to detect antibodies to hepatitis C virus (anti-HCV) in 154 patients with haemophilia. Prevalence of anti-HCV was associated with…”
Get more information

Familial thrombophilia: genetic risk factors and management by MAKRIS, M., ROSENDAAL, F.R., PRESTON, F.E.

“…There are now a number of potential candidates for inherited thrombophilia but a definite causal relationship has been established for only a proportion of…”
Get full text

Heterogeneity of Hepatitis C Virus Genotypes in Hemophilia: Relationship With Chronic Liver Disease by Preston, F.E., Jarvis, L.M., Makris, M., Philp, L., Underwood, J.C.E., Ludlam, C.A., Simmonds, P.

“…In this study we have determined the hepatitis C virus (HCV) serotype and genotype in a cohort of 96 HCV-infected hemophiliacs and have examined the…”
Get full text

Factor VIII gene rearrangements in patients with severe haemophilia A by Goodeve, A C, Preston, F E, Peake, I R

“…Sequences within intron 22 of the factor VIII (FVIII) gene have been implicated in the cause of haemophilia in almost 50% of severely affected patients. The…”
Get more information

Hepatitis C Viral RNA in Clotting Factor Concentrates and the Development of Hepatitis in Recipients by Makris, M., Garson, J.A., Ring, C.J.A., Tuke, P.W., Tedder, R.S., Preston, F.E.

“…The polymerase chain reaction (PCR) was used to detect hepatitis C (HCV) viral sequences (HCV-RNA) in clotting factor concentrates that had been stored at 4°C…”
Get full text

A Randomized Controlled Trial of Recombinant Interferon-α in Chronic Hepatitis C in Hemophiliacs by Makris, M., Preston, F.E., Triger, D.R., Underwood, J.C.E., Westlake, L., Adelman, M.I.

“…Chronic liver disease associated with hepatitis C virus (HCV) is an important cause of morbidity and mortality in hemophilia. We have used recombinant…”
Get full text